Cargando…

Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer

The receptor tyrosine kinase Mer (gene name Mertk) acts in vascular endothelial cells (ECs) to tighten the blood-brain barrier (BBB) subsequent to viral infection, but how this is achieved is poorly understood. We find that Mer controls the expression and activity of a large cohort of BBB regulators...

Descripción completa

Detalles Bibliográficos
Autores principales:	Happonen, Kaisa E., Burrola, Patrick G., Lemke, Greg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482977/ https://www.ncbi.nlm.nih.gov/pubmed/37673933 http://dx.doi.org/10.1038/s42003-023-05287-y

Ejemplares similares

The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages
por: Jiménez-García, Lidia, et al.
Publicado: (2022)

Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer
por: Zagórska, Anna, et al.
Publicado: (2020)

Microglia use TAM receptors to detect and engulf amyloid beta plaques
por: Huang, Youtong, et al.
Publicado: (2021)

TAM receptors regulate multiple features of microglial physiology
por: Fourgeaud, Lawrence, et al.
Publicado: (2016)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

Diversification of TAM receptor function
por: Zagórska, Anna, et al.
Publicado: (2014)

Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells
por: Dransfield, I, et al.
Publicado: (2015)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

Blood clots and TAM receptor signalling in COVID-19 pathogenesis
por: Lemke, Greg, et al.
Publicado: (2020)

Structural insights into the inhibited states of the Mer receptor tyrosine kinase
por: Huang, Xudong, et al.
Publicado: (2009)

Phosphorylation of Ack1 by the Receptor Tyrosine Kinase Mer
por: Hayashi, Samantha Y., et al.
Publicado: (2023)

TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
por: Schmitz, Robin, et al.
Publicado: (2016)

Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function
por: Lee, Chang-Hee, et al.
Publicado: (2019)

Early death in a mouse model of Alzheimer’s disease exacerbated by microglial loss of TAM receptor signaling
por: Huang, Youtong, et al.
Publicado: (2022)

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase
por: Kimani, Stanley G., et al.
Publicado: (2016)

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
por: Myers, Kayla V., et al.
Publicado: (2019)

The Variations of MER Receptor Tyrosine Kinase and the Development of Chronic Obstructive Pulmonary Disease
por: Oh, Dong Kyu, et al.
Publicado: (2018)

The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
por: Miner, Jonathan J., et al.
Publicado: (2015)

Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis
por: Zhou, Yandan, et al.
Publicado: (2023)

Mechanisms of autoimmunity in mice lacking the mer membrane tyrosine kinase
por: Cohen, PL, et al.
Publicado: (2004)

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2013)

Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
por: Schoumacher, Marie, et al.
Publicado: (2017)

Endothelial receptor tyrosine kinases involved in angiogenesis
Publicado: (1995)

Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment
por: Wang, Kai-Hung, et al.
Publicado: (2020)

Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors
por: Puputti, Marjut, et al.
Publicado: (2009)

The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
por: Zhu, Huaqun, et al.
Publicado: (2014)

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2016)

Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins
por: Zizzo, Gaetano, et al.
Publicado: (2023)

Targeting the TAM Receptors in Leukemia
por: Huey, Madeline G., et al.
Publicado: (2016)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells
por: Park, Hyun-Jung, et al.
Publicado: (2012)

Disrupting Mer receptor tyrosine kinase expression prevents autoimmune chronic graft-versus-host disease
por: Shao, Wen-Hai, et al.
Publicado: (2007)

Defective Efferocytosis in a Murine Model of Sjögren’s Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor
por: Witas, Richard, et al.
Publicado: (2021)

TAM receptors: two pathways to regulate adult neurogenesis
por: Johnson, Kassandra, et al.
Publicado: (2015)

Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models
por: Waterborg, Claire E. J., et al.
Publicado: (2018)

Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers
por: Grabiec, Aleksander M, et al.
Publicado: (2018)

Study of the Role of the Tyrosine Kinase Receptor MerTK in the Development of Kidney Ischemia-Reperfusion Injury in RCS Rats
por: Pelé, Thomas, et al.
Publicado: (2021)

Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
por: Hsu, Jeff, et al.
Publicado: (2023)

TAM receptors, Phosphatidylserine, inflammation, and Cancer
por: Burstyn-Cohen, Tal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_77rki1rd17id9ii7t3rg7j5t5f